相关实验视频

Updated: Jun 29, 2025

Production of Human CRISPR-Engineered CAR-T Cells

Production of Human CRISPR-Engineered CAR-T Cells

Published on: March 15, 2021

采用CRISPR/Cas9介导的定制策略,用于采用T细胞治疗

Hyeseon Park¹, Yoo Kyung Kang², Gayong Shim¹

¹School of Systems Biomedical Science and Integrative Institute of Basic Sciences, Soongsil University, Seoul 06978, Republic of Korea.

|March 28, 2024

概括

集群定期间隔的短巴林德罗姆重复关联蛋白Cas9 (CRISPR/Cas9) 技术通过精确编辑基因组以进行向治疗,彻底改变了癌症免疫疗法. 它增强了免疫细胞工程和采用细胞疗法,提供个性化癌症护理.

科学领域:

生物技术是生物技术.
免疫学免疫学免疫学
遗传学是一个遗传学.

背景情况:

来自细菌防御系统的CRISPR/Cas9技术提供了精确的基因组编辑能力.
它已成为癌症免疫疗法的强大工具,超越了传统的基因编辑方法.
在免疫检查点阻塞策略中,CRISPR/Cas9专门针对PD-1/PD-L1通路.

研究的目的:

审查CRISPR/Cas9在癌症免疫治疗中的发展和应用.
突出CRISPR/Cas9在免疫检查点控制和免疫细胞工程中的作用.
讨论CRISPR/Cas9在癌症治疗中的当前临床试验状态和未来潜力.

主要方法:

通过CRISPR/Cas9.9进行基因组编辑.
免疫细胞工程用于采用细胞疗法.
针对PD-1/PD-L1通道进行免疫检查点阻塞.

主要成果:

克里斯普尔/卡斯9能够进行精确的基因组修改,以提高癌症免疫疗法.
该技术通过改善免疫细胞特性来优化采用细胞疗法.
在准免疫检查点方面,CRISPR/Cas9显著有前途.

结论:

克里斯普尔/卡斯9技术是癌症免疫疗法的转型工具,提供个性化的治疗策略.
需要进一步的研究来解决安全问题,包括非目标效应和意外突变.
克里斯普技术的持续进步有可能彻底改变癌症治疗模式.

关键词:

这就是CRISPR/Cas9的作用.通过T细胞治疗治疗.癌症免疫疗法免疫疗法免疫检查点是一个检查点.

更多相关视频

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...